This study examined whether NF-κB activation and NF-κB-dependent antiviral signaling contributes to resistance to VSV infection in the PC3 cell line, derived from an aggressive metastatic prostate cancer (PrCa) tumor. The gene discussed is NFKB1; the disease is neoplasm.